Armata Pharmaceuticals, Inc. (ARMP)

Armata Pharmaceuticals Statistics

Total Valuation

ARMP has a market cap or net worth of $292.46 million. The enterprise value is $666.52 million.

Market Cap	292.46M
Enterprise Value	666.52M

Important Dates

The last earnings date was Wednesday, May 13, 2026, after market close.

Earnings Date	May 13, 2026
Ex-Dividend Date	n/a

Share Statistics

ARMP has 36.70 million shares outstanding. The number of shares has increased by 0.41% in one year.

Current Share Class	36.70M
Shares Outstanding	36.70M
Shares Change (YoY)	+0.41%
Shares Change (QoQ)	+0.49%
Owned by Insiders (%)	0.24%
Owned by Institutions (%)	10.71%
Float	11.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	57.21
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	128.13
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.64

Current Ratio	0.64
Quick Ratio	0.52
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1.72

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-25.32%
Return on Invested Capital (ROIC)	-27.82%
Return on Capital Employed (ROCE)	-52.53%
Weighted Average Cost of Capital (WACC)	7.29%
Revenue Per Employee	$85,279
Profits Per Employee	-$4.63M
Employee Count	61
Asset Turnover	0.07
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +293.27% in the last 52 weeks. The beta is 1.32, so ARMP's price volatility has been higher than the market average.

Beta (5Y)	1.32
52-Week Price Change	+293.27%
50-Day Moving Average	9.89
200-Day Moving Average	6.88
Relative Strength Index (RSI)	42.46
Average Volume (20 Days)	77,986

Short Selling Information

The latest short interest is 230,017, so 0.63% of the outstanding shares have been sold short.

Short Interest	230,017
Short Previous Month	297,898
Short % of Shares Out	0.63%
Short % of Float	1.99%
Short Ratio (days to cover)	3.58

Income Statement

In the last 12 months, ARMP had revenue of $5.20 million and -$282.61 million in losses. Loss per share was -$7.78.

Revenue	5.20M
Gross Profit	-10.52M
Operating Income	-31.82M
Pretax Income	-282.61M
Net Income	-282.61M
EBITDA	-30.21M
EBIT	-31.82M
Loss Per Share	-$7.78

Balance Sheet

The company has $4.75 million in cash and $373.67 million in debt, with a net cash position of -$368.92 million or -$10.05 per share.

Cash & Cash Equivalents	4.75M
Total Debt	373.67M
Net Cash	-368.92M
Net Cash Per Share	-$10.05
Equity (Book Value)	-311.59M
Book Value Per Share	-8.50
Working Capital	-3.28M

Cash Flow

In the last 12 months, operating cash flow was -$23.97 million and capital expenditures -$506,000, giving a free cash flow of -$24.47 million.

Operating Cash Flow	-23.97M
Capital Expenditures	-506,000
Depreciation & Amortization	1.61M
Net Borrowing	15.00M
Free Cash Flow	-24.47M
FCF Per Share	-$0.67

Margins

Gross Margin	-202.13%
Operating Margin	-611.61%
Pretax Margin	-5,432.80%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ARMP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.41%
Shareholder Yield	-0.41%
Earnings Yield	-94.97%
FCF Yield	-8.22%

Analyst Forecast

The average price target for ARMP is $17.50, which is 119.57% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$17.50
Price Target Difference	119.57%
Analyst Consensus	Strong Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	73.01%
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	4